We are live on
!
Find out more
SAM
Sectoral Asset Management Portfolio holdings
AUM
$121M
1-Year Est. Return
73.47%
This Fund
S&P 500
This Quarter
Est. Return
+29.7%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$1.09B
AUM Growth
+$568M
(+109%)
Cap. Flow
+$422M
Cap. Flow
% of AUM
38.69%
Top 10 Holdings %
Top 10 Hldgs %
23.6%
Holding
197
New
132
Increased
39
Reduced
16
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Centene
CNC
|
+$26.1M |
| 2 |
ARNA
Arena Pharmaceuticals Inc
ARNA
|
+$20M |
| 3 |
Arvinas
ARVN
|
+$19.8M |
| 4 |
BPMC
Blueprint Medicines
BPMC
|
+$19.7M |
| 5 |
CSII
Cardiovascular Systems, Inc.
CSII
|
+$18.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Aprea Therapeutics
APRE
|
+$18.2M |
| 2 |
KYNB
Kyntra Bio
KYNB
|
+$12M |
| 3 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
+$10.7M |
| 4 |
Teladoc Health
TDOC
|
+$10.1M |
| 5 |
Biogen
BIIB
|
+$8.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 86.26% |
| 2 | Industrials | 4.93% |
| 3 | Technology | 1.47% |
| 4 | Energy | 0.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Iovance Biotherapeutics
IOVA
$1.82B
| $571K | 0.05% |
+20,800
| New | +$684K |
|
127
argenx
ARGX
$53.4B
| $563K | 0.05% |
+2,500
| New | +$444K |
|
|
SYNH
128
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $562K | 0.05% |
+9,650
| New | +$519K |
|
|
RETA
129
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $562K | 0.05% |
3,600
-70,409
| -95% | -$10.7M |
|
130
Halozyme
HALO
$9.79B
| $558K | 0.05% |
+20,800
| New | +$469K |
|
131
Zai Lab
ZLAB
$2.06B
| $558K | 0.05% |
+6,800
| New | +$460K |
|
132
ICU Medical
ICUI
$4.21B
| $553K | 0.05% |
+3,000
| New | +$596K |
|
133
Globus Medical
GMED
$10.7B
| $544K | 0.05% |
+11,400
| New | +$550K |
|
134
Emergent Biosolutions
EBS
$373M
| $538K | 0.05% |
+6,800
| New | +$507K |
|
|
NVTA
135
DELISTED
Invitae Corporation
NVTA
| $536K | 0.05% |
+17,700
| New | +$309K |
|
136
Natera
NTRA
$38.3B
| $529K | 0.05% |
+10,600
| New | +$426K |
|
|
BHVN
137
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $526K | 0.05% |
+7,200
| New | +$383K |
|
138
Envista
NVST
$4.44B
| $519K | 0.05% |
+24,600
| New | +$461K |
|
139
Integra LifeSciences
IART
$1.29B
| $517K | 0.05% |
+11,000
| New | +$541K |
|
|
KYNB
140
Kyntra Bio
KYNB
$27.2M
| $515K | 0.05% |
508
-12,912
| -96% | -$12M |
|
141
Agios Pharmaceuticals
AGIO
$1.79B
| $503K | 0.05% |
+9,400
| New | +$435K |
|
142
NeoGenomics
NEO
$1.96B
| $489K | 0.04% |
+15,800
| New | +$438K |
|
143
Alkermes
ALKS
$8.22B
| $472K | 0.04% |
+24,300
| New | +$394K |
|
144
Omnicell
OMCL
$1.61B
| $459K | 0.04% |
+6,500
| New | +$445K |
|
|
NUVA
145
DELISTED
NuVasive, Inc.
NUVA
| $434K | 0.04% |
+7,800
| New | +$451K |
|
146
Insmed
INSM
$21.4B
| $427K | 0.04% |
+15,500
| New | +$367K |
|
|
CCXI
147
DELISTED
ChemoCentryx, Inc.
CCXI
| $391K | 0.04% |
+6,800
| New | +$370K |
|
148
Dr. Reddy's Laboratories
RDY
$9.87B
| $390K | 0.04% |
36,770
| – | – |
|
149
Medpace
MEDP
$16.1B
| $381K | 0.04% |
+4,100
| New | +$349K |
|
150
Merit Medical Systems
MMSI
$5.08B
| $379K | 0.03% |
+8,300
| New | +$335K |
|
Similar funds
RIP
LFWA
CF
WIM
MW
AFC
AAA
TGM
Sectoral Asset Management's Q2 2020 Portfolio in Review
As of Q2 2020, Sectoral Asset Management held 197 positions worth $1.09B, up 109% from $521M the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Sectoral Asset Management deployed $422M of net new capital in Q2 2020, opening 132 new positions and adding to 39 existing holdings. Its largest new stake was Centene: 401,158 shares worth $25.5M.
By sector, the portfolio is most concentrated in Healthcare at 86% of assets, up from 86% a quarter earlier, followed by Industrials and Technology.
On the sell side, the largest reduction was Aprea Therapeutics, an estimated $18.2M trimmed.
- Sectoral Asset Management's largest Q2 2020 buy was Centene: 401,158 shares worth $25.5M.
- Sectoral Asset Management added most to Cardiovascular Systems, Inc. in Q2 2020, an estimated $18.2M increase.
- Sectoral Asset Management's biggest Q2 2020 reduction was Aprea Therapeutics, cutting an estimated $18.2M.
- Sectoral Asset Management fully exited Inspire Medical Systems in Q2 2020, selling an estimated $6.81M.
- Sectoral Asset Management's ten largest holdings make up 24% of its $1.09B portfolio in Q2 2020.
- Sectoral Asset Management opened 132 new positions and closed 6 in Q2 2020.
- Sectoral Asset Management's portfolio value rose 109% quarter-over-quarter to $1.09B.
Based on Sectoral Asset Management's 13F filing for Q2 2020, filed 13 Aug 2020.